On Saturday, Nightstar Therapeutics plc (NASDAQ: NITE) announced that positive preliminary safety and efficacy data of NSR-RPGR from the dose ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE